Brain Vessels Normally Undergo Cyclic Activation and Inactivation: Evidence from Tumor Necrosis Factor-α, Heme Oxygenase-1, and Manganese Superoxide Dismutase Immunostaining of Vessels and Perivascular Brain Cells
暂无分享,去创建一个
[1] S. Zahler,et al. Endothelial function and hemostasis , 2000, Zeitschrift für Kardiologie.
[2] W. Aird,et al. Vascular-bed--specific hemostasis and hypercoagulable states. , 1999, The New England journal of medicine.
[3] J. Hoidal,et al. TNF-α and IL-1α induce heme oxygenase-1 via protein kinase C, Ca2+, and phospholipase A2 in endothelial cells. , 1999, American journal of physiology. Heart and circulatory physiology.
[4] C. Epstein,et al. Increased Oxidative Damage Is Correlated to Altered Mitochondrial Function in Heterozygous Manganese Superoxide Dismutase Knockout Mice* , 1998, The Journal of Biological Chemistry.
[5] L. Noble,et al. Induction of heme oxygenase-1 (HO-1) in the contused spinal cord of the rat , 1998, Brain Research.
[6] T. Nagaraja,et al. Intracellular acidification induced by passive and active transport of ammonium ions in astrocytes. , 1998, American journal of physiology. Cell physiology.
[7] B. Ames,et al. The free radical theory of aging matures. , 1998, Physiological reviews.
[8] J. Hoidal,et al. Effect of tumor necrosis factor-α and interleukin-1α on heme oxygenase-1 expression in human endothelial cells. , 1998, American journal of physiology. Heart and circulatory physiology.
[9] Manuel Buttini,et al. Lipopolysaccharide induces expression of tumour necrosis factor alpha in rat brain: inhibition by methylprednisolone and by rolipram , 1997, British journal of pharmacology.
[10] S. Tonegawa,et al. Reduced stress defense in heme oxygenase 1-deficient cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. Maines,et al. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. , 1997, European journal of biochemistry.
[12] S. Shackford,et al. Production of tumor necrosis factor-alpha and interleukin-1beta by human cerebral microvascular endothelium after percussive trauma. , 1997, The Journal of trauma.
[13] C. Duyckaerts,et al. Tumor necrosis factor-α, microglia and astrocytes in AIDS dementia complex , 1997, Acta Neuropathologica.
[14] A. Sauter,et al. Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat , 1996, Neuroscience.
[15] J. Hallenbeck,et al. Inflammatory reactions at the blood-endothelial interface in acute stroke. , 1996, Advances in neurology.
[16] E. Wang,et al. Modelling the effects of age-related mtDNA mutation accumulation; complex I deficiency, superoxide and cell death. , 1995, Biochimica et biophysica acta.
[17] B. Dwyer,et al. Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. , 1995, Brain research. Molecular brain research.
[18] C. Saper,et al. Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[19] W. Erl,et al. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[20] P. Young,et al. Tumor necrosis factor-alpha expression in ischemic neurons. , 1994, Stroke.
[21] M. Cuzner,et al. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. , 1993, Cytokine.
[22] P. Borm,et al. Cell and tissue responses to oxidative damage. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[23] G. Feuerstein,et al. Increased Release of Tumor Necrosis Factor‐α Into the Cerebrospinal Fluid and Peripheral Circulation of Aged Rats , 1993, Stroke.
[24] T. Yue,et al. Release of Proinflammatory and Prothrombotic Mediators in the Brain and Peripheral Circulation in Spontaneously Hypertensive and Normotensive Wistar‐Kyoto Rats , 1992, Stroke.
[25] J. Eaton,et al. Ferritin: a cytoprotective antioxidant strategem of endothelium. , 1992, The Journal of biological chemistry.
[26] D. Wallace. Mitochondrial genetics: a paradigm for aging and degenerative diseases? , 1992, Science.
[27] A. Malik,et al. Tumor necrosis factor-alpha-mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2. , 1992, The Journal of clinical investigation.
[28] A. Jovicić,et al. Circadian variations of platelet aggregability and fibrinolytic activity in patients with ischemic stroke. , 1991, Thrombosis research.
[29] G. Feuerstein,et al. Lipopolysaccharide-induced production of tumor necrosis factor activity in rats with and without risk factors for stroke , 1991, Brain Research.
[30] H. Gerlach,et al. Endothelium and regulation of coagulation. , 1991, Diabetes care.
[31] G. Labrecque,et al. Biological rhythms in the physiology and pharmacology of blood coagulation. , 1991, Chronobiology international.
[32] R. Cotran,et al. Cytokines and endothelial cell biology. , 1990, Physiological reviews.
[33] G. Feuerstein,et al. Effect of gram-negative endotoxin on levels of serum corticosterone, TNF alpha, circulating blood cells, and the survival of rats. , 1990, Circulatory shock.
[34] W. Dougall,et al. Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response. , 1990, The Journal of biological chemistry.
[35] M. Fishbein,et al. Detection and localization of tumor necrosis factor in human atheroma. , 1990, The American journal of cardiology.
[36] A. Davison,et al. Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? , 1990, Free radical biology & medicine.
[37] M. Shin,et al. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[38] Daniel B Hier,et al. Morning increase in onset of ischemic stroke. , 1989, Stroke.
[39] Sangkot Marzuki,et al. MITOCHONDRIAL DNA MUTATIONS AS AN IMPORTANT CONTRIBUTOR TO AGEING AND DEGENERATIVE DISEASES , 1989, The Lancet.
[40] P. Libby,et al. Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. , 1989, Journal of immunology.
[41] W. Chandler,et al. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). , 1989, Circulation.
[42] D. Goeddel,et al. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism , 1988, Science.
[43] B. Ames,et al. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[44] P. Kochanek,et al. Stroke risk factors prepare rat brainstem tissues for modified local Shwartzman reaction. , 1988, Stroke.
[45] B. Ames,et al. Bilirubin is an antioxidant of possible physiological importance. , 1987, Science.
[46] H. Marver,et al. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. , 1968, Proceedings of the National Academy of Sciences of the United States of America.
[47] G. Shwartzman. STUDIES ON BACILLUS TYPHOSUS TOXIC SUBSTANCES : II. THE EFFECT OF SERA UPON THE FACTORS DETERMINING LOCAL SKIN REACTIVITY TO FILTRATES OF BACILLUS TYPHOSUS CULTURES. , 1929 .
[48] G. Shwartzman. STUDIES ON BACILLUS TYPHOSUS TOXIC SUBSTANCES , 1928, The Journal of experimental medicine.